Key Facts GPs Should Know About GLP-1 Analogs
Family Medicine Initiative
APRIL 9, 2024
Yes, one year after stopping the medication, patients regain ½ – ⅔ of their previous weight loss: What are other clinical benefits? 13 Here is some evidence: From 2004-2020, 8,718 GLP-1 analogs-associated tumors were reported to the FDA. Tirzepatide (15 mg) showed slightly more noticeable effects than Semaglutide (2.4
130 
Let's personalize your content